中性粒细胞限制了CCRL2基因变异对COVID-19严重性的贡献

Mattia Laffranchi1,2, Elvezia Maria Paraboschi3,4, Francisco Bianchetto-Aguilera5

  • 1Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Heliyon
|January 15, 2025
PubMed
概括

3p21.31位点的遗传变异,特别是CCRL2,与严重的COVID-19有关. 这些变异影响中性粒细胞的功能,增加了欧洲人住院的风险.